abstract |
The present invention relates to the use of a 1- [2-naphthylethyl] -4- (3-trifluoromethylphenyl) -1,2,3,6-tetrahydropyridine of formula (I) or its addition salts with pharmaceutically acceptable acids, for the preparation of cardioprotective medicaments. |